BSGM: BioSig Technologies, Inc. Stock

SIC 3845 – Electromedical and Electrotherapeutic Apparatus

Valuation
Market Cap ($M) 34.80
Enterprise Value ($M) 34.78
Book Value ($M) -1.42
Book Value / Share -0.06
Price / Book -24.47
NCAV ($M) -1.92
NCAV / Share -0.08
Price / NCAV -18.13

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -6.50
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 0.15
Current Ratio 0.15

Balance Sheet (mrq) ($M)
Current Assets 0.34
Assets 0.84
Liabilities 2.26
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.04
Operating Income -12.61
Net Income -10.33
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -4.76
Cash from Investing 0.00
Cash from Financing 4.71

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
11-14 13G/A Armistice Capital, Llc 4.99 -84.73

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-04-15 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2024 ☐ TRANSITION REPORT UNDER SECTON 13.0
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One)
2024-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One)
2024-05-20 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One)

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-06 68,958 201,824 34.17
2025-05-05 388,434 1,162,687 33.41
2025-05-02 219,308 479,800 45.71

(click for more detail)

Similar Companies
BEAT – HeartBeam, Inc. BJDX – Bluejay Diagnostics, Inc.
BLFS – BioLife Solutions, Inc. CHEK – Check-Cap Ltd.
CLPT – ClearPoint Neuro, Inc.


Financial data and stock pages provided by
Fintel.io